Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension

Progress in Cardiovascular Diseases

Volumn 45, Issue 3, 2002, Pages 173-202

  Jeffery, T K ^a   Morrell, N W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BLOOD VESSEL WALL; CELL HETEROGENEITY; DEVELOPMENTAL STAGE; EXTRACELLULAR MATRIX; HUMAN; HYPOXIA; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG CIRCULATION; NONHUMAN; PULMONARY ARTERY; PULMONARY HYPERTENSION; RESISTANCE BLOOD VESSEL; REVIEW; SMOOTH MUSCLE;

EID: 0036875930     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2002.130041     Document Type: Review

References (293)

1. Bishop JE, Butt RP, Low RB: The effect of mechanical forces on cell function: Implications for pulmonary vascular remodeling due to hypertension, in Bishop JE, Reeves JT,Laurent GJ(eds): Pulmonary Vascular Remodelling. London, Portland Press, 1995, pp 213-239
2. deMello DE, Sawyer D, Galvin N, et al: Early fetal development of lung vasculature. Am J Respir Cell Mol Biol 16:568-571, 1997
3. Davies P, Maddalo F, Reid L: Effects of chronic hypoxia on structure and reactivity of rat lung microvessels. J Appl Physiol 58:795-801, 1985
4. Hislop A, Reid L: New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol 57:542-554, 1976
5. Meyrick B, Reid L: Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am J Pathol 100:151-178, 1980
6. Meyrick B, Reid L: The effect of continued hypoxia on rat pulmonary arterial circulation. Lab Invest 38:188, 1978
7. Jones R, Jacobson M, Steudel W: αSmooth muscle actin and microvascular precursor smooth-muscle cells in pulmonary hypertension. Am J Respir Cell Mol Biol 20:582-594, 1999
8. Heath D: Pulmonary vascular disease, in Spencer's Pathology of the Lung. London, McGraw-Hill, 1996, pp 649-693
9. Wagenvoort CA, Wagenvoort N: Primary pulmonary hypertension. A pathological study of the lung vessels in 156 clinically diagnosed cases. Circulation 42:1163-1184, 1970
10. Ilkiw R, Todorovich-Hunter L, Maruyama K, et al: SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats. Circ Res 64:814-825, 1989
11. Maruyama K, Ye CL, Woo M, et al: Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am J Physiol 261:H1716-H1726, 1991
12. Yi ES, Kim H, Ahn H, et al: Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. Am J Respir Crit Care Med 162:1577-1586, 2000
13. Botney MD, Parks WC, Crouch EC, et al: Transforming growth factor-β1 is decreased in remodeling hypertensive bovine pulmonary arteries. J Clin Invest 89:1629-1635, 1992
14. Botney MD: Role of hemodynamics in pulmonary vascular remodeling. Am J Respir Crit Care Med 159:361-364, 1999
15. Okada K, Tanaka Y, Bernstein M, et al: Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol 151:1019-1025, 1997
16. Morrell NW, Yang X, Upton PD, et al: Altered growth responses of human pulmonary artery smooth muscle and neointimal cells from patients with pulmonary hypertension. Am J Respir Crit Care Med 159:696, 1999
17. Shi Y, O'Brien JE, Fard A, et al: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94:1655-1664, 1996
18. Scott NA, Cipolla GD, Ross CE, et al: Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93:2178-2187, 1996
19. Li G, Chen SJ, Oparil S, et al: Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 101:1362-1365, 2000
20. Atkinson C, Stewart S, Upton PD, et al: Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105:1672-1678, 2002
21. Hirose S, Hosoda Y, Furuya S, et al: Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int 50:472-479, 2000
22. Tuder RM, Chacon M, Alger L, et al: Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis. J Pathol 195:367-374, 2001
23. Cool CD, Stewart JS, Werahera P, et al: Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Am J Pathol 155:411-419, 1999
24. Lee SD, Shroyer KR, Markham NE, et al: Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101:927-934, 1998
25. Voelkel NF, Tuder RM, Weir EK: Pathophysiology of primary pulmonary hypertension: From physiology to molecular mechanisms, in Rubin LJ, Rich S (eds): Primary pulmonary hypertension. New York, Marcel Dekker, 1997, pp 83-129
26. 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall. Am J Pathol 96:51-70, 1979
27. Stiebellehner L, Belknap JK, Ensley B, et al: Lung endothelial cell proliferation in normal and pulmonary hypertensive neonatal calves. Am J Physiol 275:L593-L600, 1998
28. McKenzie JC, Clancy J, Klein RM: Autoradiographic analysis of cell proliferation and protein synthesis in the pulmonary trunk of rats during the early development of hypoxia-induced pulmonary hypertension. Blood Vessels 21:80-89, 1984
29. Meyrick B, Reid L: Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia. A quantitative ultrastructural study. Lab Invest 42:603-615, 1980
30. Vyas-Somani AC, Aziz S, Arcot SA, et al: Temporal alterations in basement membrane components in the pulmonary vasculature of the chronically hypoxic rat: Impact of hypoxia and recovery. Am J Med Sci 312:54-67, 1996
31. Dschietzig T, Richter C, Bartsch C, et al: Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium. Biochem Biophys Res Commun 289:245-251, 2001
32. Everett AD, LeCras TD, Xue C, et al: eNOS expression is not altered in pulmonary vascular remodelling due to increased pulmonary blood flow. Am J Physiol 274:L1058-L1065, 1998
33. Fisher AB, Chien S, Barakat AI, et al: Endothelial cellular responses to altered shear stress. Am J Physiol 281:L529-L533, 2001
34. Rabinovitch M, Bothwell T, Hayakawa BN, et al: Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest 55:632-653, 1986
35. Todorovich-Hunter L, Johnson DJ, Ranger P, et al: Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study. Lab Invest 58:184-195, 1988
36. Hassell KL. Altered hemostasis in pulmonary hypertension. Blood Coagul Fibrinolysis 9:107-117, 1998
37. Frank H, Mlczoch J, Huber K, et al: The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 112:714-721, 1997
38. Fisher MA, Del Vecchio PJ, Palace GP, et al: Thrombin-mediated release of lipids from pulmonary artery endothelial cells promotes neutrophil adherence. Circ Res 68:930-939, 1991
39. Bogatkevich GS, Tourkina E, Silver RM, et al: Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem 276:45184-45192, 2001
40. Howell DC, Goldsack NR, Marshall RP, et al: Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 159:1383-1395, 2001
41. Bizios R, Lai LC, Cooper JA, et al: Thrombin-induced adherence of neutrophils to cultured endothelial monolayers: Increased endothelial adhesiveness. J Cell Physiol 134:275-280, 1988
42. Gray AJ, Bishop JE, Reeves JT, et al: Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am J Respir Cell Mol Biol 12:684-690, 1995
43. Welsh CH, Hassell KL, Badesch DB, et al: Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest 110:710-717, 1996
44. Turitto VT, Hall CL: Mechanical factors affecting hemostasis and thrombosis. Thromb Res 92:S25-S31, 1998
45. Prosser IW, Stenmark KR, Suthar M, et al: Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am J Pathol 135:1073-1088, 1989
46. Hirschi KK, D'Amore PA: Pericytes in the microvasculature. Cardiovasc Res 32:687-698, 1996
47. Frid MG, Moiseeva EP, Stenmark KR: Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res 75:669-681, 1994
48. Frid MG, Aldashev AA, Dempsey EC, et al: Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities. Circ Res 81:940-952, 1997
49. Dempsey EC, Frid MG, Aldashev AA, et al: Heterogeneity in the proliferative response of bovine pulmonary artery smooth muscle cells to mitogens and hypoxia: Importance of protein kinase C. Can J Physiol Pharmacol 75:936-944, 1997
50. 1 and bone morphogenetic proteins. Circulation 104:790-795, 2001
51. Upton PD, Wharton J, Davie N, et al: Differential adrenomedullin release and endothelin receptor expression in distinct subpopulations of human airway smooth-muscle cells. Am J Respir Cell Mol Biol 25:316-25, 2001
52. 1 receptors. Am J Physiol 277:L440-L448, 1999
53. Wharton J, Davie N, Upton PD, et al: Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation 102:3130, 2000
54. Riley DJ, Poiani GJ, Tozzi CA, et al: Collagen and elastin gene expression in the hypertensive pulmonary artery of the rat. Trans Assoc Am Phys 99:180-188, 1986
55. Mecham RP, Whitehouse LA, Wrenn DS, et al: Smooth muscle mediated-connective tissue remodelling in pulmonary hypertension. Science 237:423-426, 1987
56. Tozzi CA, Christiansen DL, Poiani GJ, et al: Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility. Am J Respir Crit Care Med 149:1317-1326, 1994
57. Stenmark KR, Mecham RP: Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59:89-144, 1997
58. Straus BH, Rabinovitch M: Adventitial fibroblasts. Defining a role in vessel wall remodeling. Am J Respir Cell Mol Biol 22:1-3, 2000
59. Chazova I, Loyd JE, Zhdanov VS, et al: Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension. Am J Pathol 146:389-397, 1995
60. Stenmark KR, Fasules J, Hyde DM, et al: Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300m. J Appl Physiol 62:821-830, 1987
61. Das M, Stenmark KR, Dempsey EC: Enhanced growth of fetal and neonatal pulmonary artery adventitial fibroblasts is dependent on protein kinase C. Am J Physiol 269:L660-L667, 1995
62. Das M, Stenmark KR, Ruff LJ, et al: Selected isozymes of PKC contribute to augmented growth of fetal and neonatal bovine PA adventitial fibroblasts. Am J Physiol 273:L1276-L1284, 1997
63. Das M, Dempsey EC, Reeves JT, et al: Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol 282:L976-986, 2002
64. Das M, Bouchey DM, Moore MJ, et al: Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G protein-mediated activation of mitogen-activated protein kinases. J Biol Chem 276:15631-15640, 2001
65. Das M, Dempsey EC, Bouchey D, et al: Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts. Am J Respir Cell Mol Biol 22:15-25, 2000
66. Heath D, Yacoub M: Lung mast cells in plexogenic pulmonary arteriopathy. J Clin Pathol 44:1003-1006, 1991
67. Caslin AW, Heath D, Madden B, et al: The histopathology of 36 cases of plexogenic pulmonary arteriopathy. Histopathology 16:9-19, 1990
68. Tuder RM, Groves B, Badesch DB, et al: Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144:275-285, 1994
69. Tuder RM, Voelkel NF: Pulmonary hypertension and inflammation. J Lab Clin Med 132:16-24, 1998
70. Kimura H, Kasahara Y, Kurosu K, et al: Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monoctye chemoattractant protein-1. Lab Invest 78:571-581, 1998
71. Dorfmuller P, Zarka V, Durand-Gasselin I, et al: Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 165:534-539, 2002
72. Balabanian K, Foussat A, Dorfmuller P, et al: CX3C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 165:1419-1425, 2002
73. Peinado VI, Barbera JA, Abate P, et al: Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:1605-1611, 1999
74. Reeves JT, Bishop JE, Laurent GJ: Functional basis for the structure of the pulmonary arterial tree, in Bishop JE, Reeves JT, Laurent GJ (eds): Pulmonary Vascular Remodelling. London, Portland Press, 1995, pp 1-19
75. Tozzi CA, Poiani GJ, Harangozo AM, et al: Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J Clin Invest 84:1005-1012, 1989
76. Thomas HC, Lame MW, Dunston SK, et al: Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells. Toxicol Appl Pharmacol 151:236-244, 1998
77. Yeager ME, Halley GR, Golpon HA, et al: Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 88:e2-e11, 2001
78. Riley DJ, Thakker-Varia S, Wilson FJ, et al: Role of proteolysis and apoptosis in regression of pulmonary vascular remodelling. Physiol Res 49:577-585, 2000
79. Cowan KN, Heilbut A, Humpl T, et al: Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6:698-702, 2000
80. Massague J, Chen Y-G: Controlling TGF-β signaling. Genes Dev 14:627-644, 2000
81. Massagué J, Blain SW, Lo RS: TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103:295-309, 2000
82. The International PPH Consortium, Lane KB, Machado RD, et al: Heterozygous germ-line mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat Genet 26:81-84, 2000
83. Deng Z, Morse JH, Slager SL, et al: Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67:737-744, 2000
84. Thomson JR, Machado RD, Pauclulo MW, et al: Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family. J Med Genet 37:741-745, 2000
85. Trembath RC, Thomson JR, Machado RD, et al: Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345:325-334, 2001
86. Rosenzweig BL, Imamura T, Okadome T, et al: Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636, 1995
87. Kawabata M, Imamura T, Miyazano K: Signal transduction by bone morphogenetic proteins. Cytokine and Growth Factor Rev 9:49-61, 1998
88. Raftery LA, Sutherland DJ: TGF-β family signal transduction in Drosophila development: From Mad to Smads. Dev Biol 210:251-268, 1999
89. Wrana JL: Crossing Smads. Science's STKE 23:1-9, 2000
90. Yamamura Y, Hua X, Bergelson S, et al: Critical role of Smads and AP-1 complex in transforming growth factor-beta-dependent apoptosis. J Biol Chem 275:36295-36302, 2000
91. Onichtchouk D, Chen Y-G, Dosch R, et al: Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401:480-485, 1999
92. Afrakhte M, Moren A, Jossan S, et al: Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem Biophys Res Commun 249:505-511, 2000
93. Long L, Scott L, Stephens R, et al: Induction of gene expression in human pulmonary artery smooth muscle cells by bone morphogenetic protein-4. Thorax 56:103, 2001
94. Itoh F, Asao H, Sugamura K, et al: Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J 20:4132-4142, 2001
95. Nohe A, Hassel S, Ehrlich M, et al: The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277:5330-5338, 2002
96. Rudarakanchana N, Flanagan JA, Chen H, et al: Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genetics 11:1517-1525, 2002
97. Beppu H, Kawabata M, Hamamoto T, et al: BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 221:249-258, 2000
98. Yang X, Castilla LH, Xin X, et al: Angiogenesis defects and mesenchymal apoptosis in mice lacking smad5. Development 126:1571-1580, 1999
99. Schulick AH, Taylor AJ, Zuo W, et al: Overexpression of transforming growth factor beta 1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci USA 95:6983-6988, 1998
100. Shah NM, Groves AK, Anderson DJ: Alternative neural crest fates are instructively promoted by TGF-β superfamily members. Cell 85:331-343, 1996
101. McCaffrey TA: TGF-βs and TGF-β receptors in atherosclerosis. Cytokine Growth Factor Rev 11:103-114, 2000
102. Dorai H, Vukicevic S, Sampath TK: Bone morphogenetic protein-7 (OP-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 184:37-45, 2000
103. Rudarakanchana N, Trembath RC, Morrell NW: New insights into the pathogenesis and treatment of primary pulmonary hypertension. Thorax 56:888-890, 2001
104. Machado RD, Pauciulo MW, Thomson JR, et al: BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68:92-102, 2001
105. Geraci MW, Moore M, Gesell T, et al: Gene expression patterns in the lungs of patients with primary pulmonary hypertension. Circ Res 88:555-562, 2001
106. Botney MD, Bahadori L, Gold LI: Vascular remodelling in primary pulmonary hypertension. Potential role for transforming growth factor-β. Am J Pathol 144:286-295, 1994
107. Kucich U, Rosenbloom JC, Abrams WR, et al: Transforming growth factor-β stabilizes elastin mRNA by a pathway requiring active smads, protein kinase C-δ, and p38. Am J Respir Cell Mol Biol 26:183-188, 2002
108. Lee SD, Lee DS, Chun YG, et al: Transforming growth factor-β induces endothelin-1 in a bovine pulmonary artery endothelial cell line and rat lungs via cAMP. Pulm Pharmacol Therap 13:257-265, 2000
109. Markewitz BA, Farrukh IS, Chen Y, et al: Regulation of endothelin-1 synthesis in human pulmonary arterial smooth muscle cells: Effects of transforming growth factor-β and hypoxia. Cardiovasc Res 49:200-206, 2001
110. Kucich U, Rosenbloom JC, Herrick DJ, et al: Signaling events required for transforming growth factor-β stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. Arch Biochem Biophys 395:103-112, 2001
111. Shehata SMK, Mooi WJ, Okazaki T, et al: Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax 54:427-431, 1999
112. Geiger R, Berger RMF, Hess J, et al: Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease. J Pathol 191:202-207, 2000
113. Lassus P, Turanlahti M, Heikkila P, et al: Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164:1981-1987, 2001
114. Eddahibi S, Humbert M, Sediame S, et al: Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med 162:1493-1499, 2000
115. Christou H, Yoshida A, Arthur V, et al: Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 18:768-776, 1998
116. Wanstall JC, Gambino A, Jeffery TK, et al: Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension. Cardiovasc Res 55:3611-3618, 2002
117. Arcot SS, Fagerland JA, Lipke DW, et al: Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats. Growth Factors 12:121-130, 1995
118. Berg JT, Breen EC, Fu Z, et al: Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma. Am J Respir Crit Care Med 158:1920-1928, 1998
119. Katayose D, Ohe M, Yamauchi K, et al: Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am J Physiol 264:L100-L106, 1993
120. Perkett EA, Badesch DB, Roessler MK, et al: Insulin-like growth factor I and pulmonary hypertension induced by continuous air embolization in sheep. Am J Respir Cell Mol Biol 6:82-87, 1992
121. Gillespie MN, Rippetoe PE, Haven CA, et al: Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension. Am Rev Respir Dis 140:1463-1466, 1989
122. Rothman A, Wolner B, Button D, et al: Immediate-early gene expression in response to hypertrophic .and proliferative stimuli in pulmonary arterial smooth muscle cells. J Biol Chem 269:6399-6404, 1994
123. Wang HL, Kilfeather SA, Martin GR, et al: Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells. Pulm Pharmacol Ther 13:53-60, 2000
124. Dempsey EC, Stenmark KR, McMurtry IF, et al: Insulin-like growth factor I and protein kinase C activation stimulate pulmonary artery smooth muscle cell proliferation through separate but synergistic pathways. J Cell Physiol 144:159-165, 1990
125. Badesch DB, Lee PDK, Parks WC, et al: Insulin-like growth factor 1 stimulates elastin synthesis by bovine pulmonary arterial smooth muscle cells. Biochem Biophys Res Commun 160:382-387, 1989
126. Noguchi A, Nelson T: IGF-1 stimulates tropoelastin synthesis in neonatal rat pulmonary fibroblasts. Pediatr Res 30:248-251, 1991
127. 2 increases expression of pulmonary artery endothelial cell platelet-derived growth factor mRNA. J Appl Physiol 73:2255-2262, 1992
128. Liu Y, Cox SR, Morita T, et al: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res 77:638-643, 1995
129. Kourembanas S, Hannan RL, Faller DV: Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest 86:670-674, 1990
130. Fisher AB, Chien S, Barakat AI, et al: Endothelial cellular response to altered shear stress. Am J Physiol Lung Cell Mol Physiol 281:L529-L533, 2001
131. Abenhaim L, Moride Y, Brenot F, et al: Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 335:609-616, 1996
132. Sato K, Webb S, Tucker A, et al: Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis 145:793-797, 1992
133. Herve P, Launay JM, Scrobohaci ML, et al: Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99:249-254, 1995
134. Lee SL, Wang WW, Lanzillo JJ, et al: Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am J Physiol 266:L46-L52, 1994
135. Fanburg BL, Lee SL: A new role for an old molecule: Serotonin as a mitogen. Am J Physiol 272:L795-L806, 1997
136. Eddahibi S, Fabre V, Boni C, et al: Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 84:329-336, 1999
137. Lee SL, Wang WW, Moore BJ, et al: Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res 68:1362-1368, 1991
138. Pitt BR, Weng W, Steve AR, et al: Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am J Physiol 266:L178-L186, 1994
139. Lee SL, Wang WW, Fanburg BL: Superoxide as an intermediate signal for serotonin-induced mitogenesis. Free Rad Biol Med 24:855-858, 1998
140. Eddahibi S, Humbert M, Fadel E, et al: Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle cell hyperplasia in primary pulmonary hypertension. J Clin Invest 108:1141-1150, 2001
141. Eddahibi S, Fabre V, Boni C, et al: Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: Relationship with the mitogenic action of serotonin. Circ Res 84:329-336, 1999
142. Eddahibi S, Hanoun N, Lanfumey L, et al: Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 105:1555-1562, 2000
143. Lee SD, Wang WW, Fanburg BL: Dexfenfluramine as a mitogen signals through the formation of superoxide anion. FASEB J 15:1324-1325, 2001
144. Archer SL, Djaballah K, Humbert M, et al: Nitric oxide deficiency in fenfluramine- and dexfenflura mine-induced pulmonary hypertension. Am J Respir Crit Care Med 158:1061-1067, 1998
145. Elton TS, Oparil S, Taylor GR, et al: Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am J Physiol 263:R1260-R1264, 1992
146. Aguirre JI, Morrell NW, Long L, et al: Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 278:L981-L987, 2000
147. Allen SW, Chatfield BA, Koppenhafer SA, et al: Circulating immunoreactive endothelin-1 in children with pulmonary hypertension: Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 148:519-522, 1993
148. Giaid A, Yanagisawa M, Langleben D, et al: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328:1732-1739, 1993
149. Langleben D, Barst RJ, Badesch D, et al: Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. Circulation 99:3266-3271, 1999
150. A-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Physiol 266:H1327-H1331, 1994
151. Hassoun PM, Thappa V, Landman MJ, et al: Endothelin 1: Mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med 199:165-170, 1992
152. Janakidevi K, Fisher MA, Del Vecchio PJ, et al: Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol 263:C1295-C1301, 1992
153. Zamora MA, Dempsey EC, Walchak SJ, et al: BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 9:429-433, 1993
154. Peacock AJ, Dawes KE, Shock A, et al: Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 7:492-499, 1992
155. Mansoor AM, Honda M, Saida K, et al: Endothelin induced collagen remodeling in experimental pulmonary hypertension. Biochem Biophys Res Commun 215:981-986, 1995
156. B receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 165:398-405, 2002
157. Soma S, Takahashi H, Muramatsu M, et al: Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. Am J Respir Cell Mol Biol 20:620-630, 1999
158. Li H, Chen SJ, Chen YF, et al: Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol 77:1451-1459, 1994
159. Ivy DD, Parker TA, Abman SH: Prolonged endothelin B receptor blockade causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 297:L758-L765, 2000
160. Ivy DD, Yanagisawa M, Gariepy CE, et al: Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. Am J Physiol Lung Cell Mol Physiol 282:L703-L712, 2002
161. 2+ by endothelin-1 in rat intrapulmonary arterial smooth muscle cells. Am J Physiol 278:L157-L164, 2000
162. Lonchampt MO, Pinelis S, Goulin J, et al: Proliferation and Na+/H+ exchange activation by endothelin in vascular smooth muscle cells. Am J Hypertens 4:776-779, 1991
163. Assender JW, Irenius E, Fredholm BB: Endothelin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells. Acta Physiol Scand 157:451-460, 1996
164. Koide M, Kawahara Y, Tsuda T, et al: Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J Hypertens 10:1173-1182, 1992
165. Bobik A, Grooms A, Millar JA, et al: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 258:C408-C415, 1990
166. Wedgwood S, Dettman RW, Black SM: ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol 281:L1058-L1067, 2001
167. Hyvelin J-M, Guibert C, Marthan R, et al: Cellular mechanisms and role of endothelin-1-induced calcium oscillations in pulmonary arterial myocytes. Am J Physiol 275:L269-L282, 1998
168. Morrell NW, Atochina EN, Morris KG, et al: Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 96:1823-1833, 1995
169. Jeffery TK, Wanstall JC: Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: Comparative effects on pulmonary vascular structure and function. Br J Pharmacol 128:1407-1418, 1999
170. Morrell NW, Morris KG, Stenmark KR: Role of angiotensin converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 269:H1186-H1194, 1995
171. Marshall RP, McAnulty RJ, Laurent GJ: Angiotensin II is mitogenic for human lung fibroblasts via activation of the type I receptor. Am J Respir Crit Care Med 161:1999-2004, 2000
172. Morrell NW, Atochina EN, Morris KG, et al: Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 96:1823-1833, 1995
173. Schuster DP, Crouch EC, Parks WC, et al: Angiotensin converting enzyme expression in primary pulmonary hypertension. Am J Respir Crit Care Med 154:1087-1091, 1996
174. Orte C, Polak JM, Haworth SG, et al: Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol 192:379-384, 2000
175. Akishita M, Masaaki I, Lehtonen JYA, et al: Expression of the AT2 receptor developmentally programs extracellular signal-related kinase activity and influences fetal vascular growth. J Clin Invest 103:63-71, 1999
176. Saito Y, Berk BC: Angiotensin II-mediated signal transduction pathways. Curr Hypertens Rep 4:167-171, 2002
177. Saito Y, Berk BC: Transactivation: A novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33:3-7, 2001
178. Berk BC: Angiotensin II signal transduction in vascular smooth muscle: Pathways activated by specific tyrosine kinases. J Am Soc Nephrol 10:S62-S68, 1999 (Suppl 11)
179. Heeneman S, Haendeler J, Saito Y, et al: Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. J Biol Chem 275:15926-15932, 2000
180. Christman BW, McPherson CD, Newman JH, et al: An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327:70-75, 1992
181. Humbert M, Monti G, Brenot F, et al: Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 151:1628-1631, 1995
182. 2 suggest macrophage activation in patients with primary pulmonary hypertension. Chest 120:1639-1644, 2001
183. Wright L, Tuder RM, Wang J, et al: 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. Am J Respir Crit Care Med 157:219-229, 1998
184. Roth M, Yousefi S, Tamm M, et al: Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J Exp Med 184:191-201, 1996
185. Libby P, Warner SJ, Friedman GB: Interleukin 1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 81:487-498, 1988
186. Cooper AL, Beasley D: Hypoxia stimulates proliferation and interleukin-1β production in human vascular smooth muscle cells. Am J Physiol 277:H1326-H1337, 1999
187. Plutzky J: Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 88:10K-15K, 2001
188. Walker JL, Loscalzo J, Zhang Y: 5-lipoxygenase and human pulmonary artery endothelial cell proliferation. Am J Physiol 2822:H585-H593, 2002
189. Hall JL, Wang W, Adamson V, et al: Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-β-independent and -dependent pathways. Circ Res 88:1247-1253, 2001
190. Yue T-L, Ni J, Romanic AM, et al: TL1, a novel tumor necrosis factor-like cytokine induces apoptosis in endothelial cells. J Biol Chem 274:1479-1486, 1999
191. Gochuico BR, Zhang J, Ma BY, et al: TRAIL expression in vascular smooth muscle. Am J Physiol 278:L1045-L1050, 2000
192. Karakurum M, Shreeniwas R, Chen J, et al: Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 93:1564-1570, 1994
193. Wong HR, Finder JD, Wasserloos K, et al: Transcriptional regulation of iNOS by IL-1 beta in cultured rat pulmonary artery smooth muscle cells. Am J Physiol 271:L166-L171, 1996
194. Rahman A, Kefer J, Bando M, et al: E-selectin expression in human endothelial cells by TNF-α-induced oxidant generation and NF-κB activation. Am J Physiol 275:L533-L544, 1998
195. Zhang J, Patel JM, Block ER: Hypoxia-specific upregulation of calpain activity and gene expression in pulmonary artery endothelial cells. Am J Physiol 275:L461-L468, 1998
196. Rahman A, Bando M, Kefer J, et al: Protein kinase C-activated oxidant generation in endothelial cells signals intracellular adhesion molecule-1 gene transcription. Mol Pharmacol 55:575-583, 1999
197. Chaqour B, Howard PS, Richards CF, et al: Mechanical stretch induces platelet-activating factor gene expression through the NF-κB transcription factor. J Mol Cell Cardiol 31:1345-1355, 1999
198. Rahman A, Anwar KN, Malik AB: Protein kinase C-ζ mediates TNF-α-induced ICAM-1 gene transcription in endothelial cells. Am J Physiol 279:C906-C914, 2000
199. Kolyada AY, Madias NE: Transcriptional regulation of the human iNOS gene by IL-1 beta in endothelial cells. Mol Med 7:329-343, 2001
200. Thannickal VJ, Day RM, Klinz SG, et al: Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGFβ1. FASEB J 14:1741-1748, 2000
201. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor β1. J Biol Chem 270:30334-30338, 1995
202. Hoshikawa Y, Ono S, Suzuki S, et al: Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol 90:1299-1306, 2001
203. A receptor antagonist (C1-1020) in rats with established hypoxic pulmonary hypertension. Pulm Pharmacol Therap 11:173-176, 1998
204. Partridge CA, Blumenstock FA, Malik AB: Pulmonary vascular endothelial cells constitutively release xanthine oxidase. Arch Biochem Biophys 294:184-187, 1992
205. Lee SL, Wang WW, Finlay GA, et al: Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am J Physiol 277:L282-L291, 1999
206. Zhang J, Jin N, Liu Y, et al: Hydrogen peroxide stimulates extracellular signal-regulated protein kinases in pulmonary arterial smooth muscle cells. Am J Respir Cell Mol Biol 19:324-332, 1998
207. Todorovich-Hunter L, Dodo H, Ye C, et al: Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease. Am Rev Respir Dis 146:213-223, 1992
208. Thompson K, Rabinovitch M: Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor. J Cell Physiol 166:495-505, 1996
209. Wigle DA, Thompson KE, Yablonsky S, et al: AML1-like transcription factor induces serine elastase activity in ovine pulmonary artery smooth muscle cells. Circ Res 83:252-263, 1998
210. Mitani Y, Zaidi SHE, Dufourcq P, et al: Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP-mediated suppression of ERK phosphorylation and AML1B nuclear partitioning. FASEB J 14:805-814, 2000
211. Northcote Cowan K, Lloyd Jones P, Rabinovitch M: Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 84:1223-1233, 1999
212. Lloyd Jones P, Cowan KN, Rabinovitch M: Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 150:1349-1360, 1997
213. Cowan KN, Jones PL, Rabinovitch M: Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105:21-34, 2000
214. Lloyd Jones P, Rabinovitch M: Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res 79:1131-1142, 1996
215. 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139:279-293, 1997
216. Jones FS, Meech R, Edelman DB, et al: Prx1 controls vascular smooth muscle cell proliferation and tenascin-C expression and is upregulated with Prx2 in pulmlonary vascular disease. Circ Res 89:131-138, 2001
217. Frisdal E, Gest V, Vieillard-Baron A, et al: Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J 18:838-845, 2001
218. Thakker-Varia S, Tozzi CA, Poiani GJ, et al: Expression of matrix-degrading enzymes in pulmonary vascular remodeling in the rat. Am J Physiol 275:L398-L406, 1998
219. Vieillard-Baron A, Frisdal E, Eddahibi S, et al: Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res 87:418-425, 2000
220. Cremona G, Bower EA, Higenbottam TW: Difference between basal release of nitric oxide and response to acetylcholine in isolated lungs from patients with chronic obstructive lung disease. Thorax 49:425P-426P, 1994
221. Dollberg S, Warner BW, Myatt L: Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation. Pediatr Res 37:31-34, 1995
222. Thomae KR, Nakayama DK, Billiar TR, et al: The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. J Surg Res 59:337-343, 1995
223. Ambalavanan N, Mariani G, Bulger A, et al: Role of nitric oxide in regulating neonatal porcine pulmonary artery smooth muscle cell proliferation. Biol Neonate 76:291-300, 1999
224. Liu X, Zhu YK, Wang H, et al: Effect of nitric oxide donors on human lung fibroblast proliferation in vitro. Chest 120:13S-14S, 2001
225. Klinger JR, Petit RD, Curtin LA, et al: Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J Appl Physiol 75:198-205, 1993
226. Zhao L, Long L, Morrell NW, et al: NPR-A-deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension. Circulation 99:605-607, 1999
227. Wilkins MR, Aldashev A, Morrell NW: Nitric oxide, phosphodiesterase inhibition, and adaptation to hypoxic conditions. Lancet 359:1539-1540, 2002
228. Kourembanas S, McQuillan LP, Leung GK, et al: Nitric oxide regulates the expression of vasocon-strictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 92:99-104, 1993
229. Brilli RJ, Krafte-Jacobs B, Smith DJ, et al: Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension. J Appl Physiol 83:1968-1975, 1997
230. + channels in pulmonary vascular smooth muscle cells. Am J Physiol 282:H184-H193, 2002
231. Hayden MA, Lange PA, Nakayama DK: Nitric oxide and cyclic guanosine monophosphate stimulate apoptosis via activation of the Fas-FasL pathway. J Surg Res 101:183-189, 2001
232. Chiche J-D, Schlutsmeyer SM, Bloch DB, et al: Adendovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the anti-proliferative and pro-apoptotic effects of nitric oxide/cGMP. J Biol Chem 273:34263-34271, 1998
233. Clapp LH, Finney P, Turcato S, et al: Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am J Respir Cell Mol Biol 26:194-201, 2002
234. Guldemeester A, Stenmark KR, Brough GH, et al: Mechanisms regulating cAMP-mediated growth of bovine neonatal pulmonary artery smooth muscle cells. Am J Physiol 276:L1010-L1017, 1999
235. Tuder RM, Cool CD, Geraci MW, et al: Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 159:1925-1932, 1999
236. Wort SJ, Mitchell JA, Woods M, et al: The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol 36:S410-S413, 2000
237. Yang L, Quan S, Abraham NG: Retrovirus-mediated HO gene transfer into enedothelial cells protects against oxidant-induced injury. Am J Physiol 277:L127-L133, 1999
238. Morita T, Perrella MA, Lee M, et al: Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92:1475-1479, 1995
239. Hartsfield CL, Alam J, Choi AMK: Differential signaling pathways of HO-1 gene expression in pulmonary and systemic vascular cells. Am J Physiol 277:L1133-L1141, 1999
240. Lee PJ, Jiang B, Chin BY, et al: Hypoxia inducible factor-1 mediates transcriptional activation of the heme-oxygenase-1 gene in response to hypoxia. J Biol Chem 272:5375-5381, 1997
241. Minamino T, Christou H, Hsieh C, et al: Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98:8798-8803, 2001
242. Yet S, Perrella MA, Layne MD, et al: Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103:R23-R29, 1999
243. Christou H, Morita T, Hsieh C, et al: Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86:1224-1229, 2000
244. Thom SR, Fisher D, Xu YA, et al: Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci USA 97:1305-1310, 2000
245. Carraway MS, Suliman HB, Carter JD, et al: Carbon monoxide promotes hypoxic pulmonary vascular remodeling. Am J Physiol 282:L693-L702, 2002
246. Welsh DJ, Scott P, Plevin R, et al: Hypoxia enhances cellular proliferation and inositol 1,4,5-triphosphate generation in fibroblasts from bovine pulmonary artery but not from mesenteric artery. Am J Respir Crit Care Med 158:1757-1762, 1998
247. Tucci M, Hammerman SI, Furfaro S, et al: Distinct effect of hypoxia on endothelial cell proliferation and cycling. Am J Physiol 272:C1700-C1708, 1997
248. Dempsey EC, McMurtry IF, O'Brien RF: Protein kinase C activation allows pulmonary artery smooth muscle cells to proliferate to hypoxia. Am J Physiol 260:L136-L145, 1991
249. Madden MC, Vender RL, Friedman M: Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium. Prostaglandins 31:1049-1062, 1986
250. Ambalavanan N, Bulger A, Philips JB: Hypoxia-induced release of peptide growth factors from neonatal porcine pulmonary artery smooth muscle cells. Biol Neonate 76:311-319, 1999
251. Klekamp JG, Jarzecka K, Hoover RL, et al: Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone. Pediatr Res 42:744-749, 1997
252. Dawes KE, Peacock AJ, Gray AJ, et al: Characterization of fibroblast mitogens and chemoattractants produced by endothelial cells exposed to hypoxia. Am J Respir Cell Mol Biol 10:552-559, 1994
253. Zamora MR, Stelzner TJ, Webb S, et al: Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am J Physiol 270:L101-L109, 1996
254. Bialecki RA, Fisher CS, Abbot BM, et al: ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat. Pulm Pharmacol Ther 12:303-312, 1999
255. Kim H, Yung GL, Marsh JJ, et al: Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J 15:640-648, 2000
256. Elton TS, Oparil S, Taylor GR, et al: Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am J Physiol 263:R1260-R1264, 1992
257. Stelzner TJ, O'Brien RF, Yanagisawa M, et al: Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am J Physiol 262:L614-L620, 1992
258. Ivy DD, Le Cras TD, Horan MP, et al: Increased lung preproET-1 and decreased ETB-receptor gene expression in fetal pulmonary hypertension. Am J Physiol 274:L535-L541, 1998
259. Nakanishi K, Tajima F, Nakata Y, et al: Expression of endothelin-1 in rats developing hypobaric hypoxia-induced pulmonary hypertension. Lab Invest 79:1347-1357, 1999
260. Chassagne C, Eddahibi S, Adamy C, et al: Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol 22:323-332, 2000
261. Zhao L, Al-Tubuly R, Sebkhi A, et al: Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br J Pharmacol 119:1217-1222, 1996
262. Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95:1798-1807, 1995
263. Partovian C, Adnot S, Eddahibi S, et al: Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol 275:H1948-H1956, 1998
264. Papakonstantinou E, Karakiulakis G, Tamm M, et al: Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells. Am J Physiol 279:L825-L834, 2000
265. Khoury J, Langleben D: Heparin-like molecules inhibit pulmonary vascular pericyte proliferation in vitro. Am J Physiol Lung Cell Mol Physiol 279:L252-L261, 2000
266. Tamm M, Bihl M, Eickelberg O, et al: Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. Am J Respir Cell Mol Biol 19:653-661, 1998
267. Palmer LA, Semenza GL, Stoler MH, et al: Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol 274:L212-L219, 1998
268. Yu AY, Frid MG, Shimoda LA, et al: Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 275:L818-L826, 1998
269. Liu Y, Cox SR, Morita T, et al: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ Res 77:638-643, 1995
270. Yu AY, Shimoda LA, Iyer NV, et al: Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest 103:691-696, 1999
271. Yan SF, Lu J, Zou YS, et al: Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 274:15030-15040, 1999
272. Yan SF, Zou YS, Gao Y, et al: Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 95:8298-8303, 1998
273. Yan SF, Lu J, Xu L, et al: Pulmonary expression of early growth response-1: Biphasic time course and effect of oxygen concentration. J Appl Physiol 88:2303-2309, 2000
274. Liu C, Adamson E, Mercola D: Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. Proc Natl Acad Sci 93:11831-11836, 1996
275. Khachigian LM, Williams AJ, Collins T: Interplay of Spl and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J Biol Chem 270:27679-27686, 1995
276. Silverman ES, Du J, De Sanctis GT, et al: Egr-1 and Spl interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants. Am J Respir Cell Mol Biol 19:316-323, 1998
277. Haas TL, Stitelman D, Davis SJ, et al: Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J Biol Chem 274:22679-22685, 1999
278. Klemm DJ, Watson PA, Frid MG, et al: cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration. J Biol Chem 276:46132-46141, 2001
279. Kito H, Chen EL, Wang X, et al: Role of mitogen-activated protein kinases in pulmonary endothelial cells exposed to cyclic strain. J Appl Physiol 89:2391-2400, 2000
280. Liu W, Liu Y, Lowe WL: The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-1-mediated effects in vascular endothelial cells. Endocrinology 142:1710-1719, 2001
281. Finlay GA, Thannickal VJ, Fanburg BL, et al: Transforming growth factor-β1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J Biol Chem 275:27650-27656, 2000
282. Yamboliev IA, Gerthoffer WT: Modulatory role of ERK MAPK-caldesmon pathway in PDGF-stimulated migration of cultured pulmonary artery SMCs. Am J Physiol 280:C1680-C1688, 2001
283. Welsh DJ, Peacock AJ, MacLean M, et al: Chronic hypoxia induces constitutive p38 mitogen activated protein kinase activity that correlates with enhanced cellular proliferation in fibroblasts from rat pulmonary but not systemic arteries. Am J Respir Crit Care Med 164:282-289, 2001
284. Scott PH, Paul A, Belham CM, et al: Hypoxic stimulation of the stress-activated protein kinases in pulmonary artery fibroblasts. Am J Respir Crit Care Med 158:958-962, 1998
285. Jin N, Hatton N, Swartz DR, et al: Hypoxia activates Jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. Am J Respir Cell Mol Biol 23:593-601, 2000
286. Kip1 is important in modulating pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 25:652-658, 2001
287. Strasser A, O'Connor L, Dixit VM: Apoptosis signaling. Annu Rev Biochem 69:217-245, 2000
288. Saikumar P, Dong Z, Mikhailov V, et al: Apoptosis: Definition, mechanisms, and relevance to disease. Am J Med 107:489-506, 1999
289. Reed JC: Mechanisms of apoptosis. Am J Pathol 157:1415-1430, 2000
290. + channels induces apoptosis in vascular smooth muscle cells. Am J Physiol 280:C970-C979, 2001
291. + channel activity and enhances survival in vascular smooth muscle cells. Am J Physiol 281:C157-C165, 2001
292. + channels in pulmonary artery smooth muscle cells of patients with priman/primary pulmonary hypertension. Circulation 98:1400-1406, 1998
293. Healy AM, Schwartz JJ, Zhu X, et al: Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells. Am J Physiol 280:L1273-L1281, 2001